A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO)

BACKGROUND: Intrahepatic cholangiocarcinoma (CCA) is amongst the most common primary liver tumors worldwide. CCA carries a bad prognosis prompting research to establish new treatment modalities other than surgery and the current chemotherapeutic regimens adopted. Hence, this trial explores a new the...

Descripción completa

Detalles Bibliográficos
Autores principales: Elias, Charbel, Zeidan, Youssef H., Bouferraa, Youssef, Mukherji, Deborah, Temraz, Sally, Charafeddine, Maya, Al Darazi, Monita, Shamseddine, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743639/
https://www.ncbi.nlm.nih.gov/pubmed/36503610
http://dx.doi.org/10.1186/s12885-022-10373-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743639/
https://www.ncbi.nlm.nih.gov/pubmed/36503610
http://dx.doi.org/10.1186/s12885-022-10373-1

Ejemplares similares